Literature DB >> 19669297

Pentoxifylline: not just for alcoholic hepatitis anymore?

Roman E Perri1, Vijay H Shah.   

Abstract

Entities:  

Year:  2008        PMID： 19669297      PMCID： PMC2716852          DOI： 10.1007/s12072-008-9057-2

Source DB:  PubMed          Journal:  Hepatol Int        ISSN： 1936-0533            Impact factor:   6.047


× No keyword cloud information.
  27 in total

Review 1.  Nonalcoholic fatty liver disease.

Authors:  Paul Angulo
Journal:  N Engl J Med       Date:  2002-04-18       Impact factor: 91.245

2.  Therapeutic effects of restricted diet and exercise in obese patients with fatty liver.

Authors:  T Ueno; H Sugawara; K Sujaku; O Hashimoto; R Tsuji; S Tamaki; T Torimura; S Inuzuka; M Sata; K Tanikawa
Journal:  J Hepatol       Date:  1997-07       Impact factor: 25.083

3.  Utility of a new model to diagnose an alcohol basis for steatohepatitis.

Authors:  Winston Dunn; Paul Angulo; Schuyler Sanderson; Laith H Jamil; Linda Stadheim; Charles Rosen; Michael Malinchoc; Patrick S Kamath; Vijay H Shah
Journal:  Gastroenterology       Date:  2006-08-10       Impact factor: 22.682

4.  Pentoxifylline improves short-term survival in severe acute alcoholic hepatitis: a double-blind, placebo-controlled trial.

Authors:  E Akriviadis; R Botla; W Briggs; S Han; T Reynolds; O Shakil
Journal:  Gastroenterology       Date:  2000-12       Impact factor: 22.682

5.  Effect of pentoxifylline in rat and swine models of hepatic fibrosis: role of fibroproliferation in its mechanism.

Authors:  T C Peterson; M Neumeister
Journal:  Immunopharmacology       Date:  1996-03

6.  Gastric bypass surgery improves metabolic and hepatic abnormalities associated with nonalcoholic fatty liver disease.

Authors:  Samuel Klein; Bettina Mittendorfer; J Christopher Eagon; Bruce Patterson; Lafaine Grant; Nikki Feirt; Ekihiro Seki; David Brenner; Kevin Korenblat; Jennifer McCrea
Journal:  Gastroenterology       Date:  2006-05       Impact factor: 22.682

7.  Effects of pentoxifylline on TNF-alpha production by peripheral blood mononuclear cells in patients with nonalcoholic steatohepatitis.

Authors:  Deniz G Duman; Filiz Ozdemir; Esra Birben; Ozlem Keskin; Emel Ekşioğlu-Demiralp; Cigdem Celikel; Omer Kalayci; Cem Kalayci
Journal:  Dig Dis Sci       Date:  2007-04-12       Impact factor: 3.199

Review 8.  Non-alcoholic steatohepatitis: what is it, and why is it important in the Asia-Pacific region?

Authors:  Geoffrey C Farrell
Journal:  J Gastroenterol Hepatol       Date:  2003-02       Impact factor: 4.029

9.  Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance.

Authors:  G S Hotamisligil; N S Shargill; B M Spiegelman
Journal:  Science       Date:  1993-01-01       Impact factor: 47.728

10.  A pilot study of the safety and tolerability of etanercept in patients with alcoholic hepatitis.

Authors:  K V Narayanan Menon; Linda Stadheim; Patrick S Kamath; Russell H Wiesner; Gregory J Gores; Craig J Peine; Vijay Shah
Journal:  Am J Gastroenterol       Date:  2004-02       Impact factor: 10.864
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.